<DOC>
	<DOCNO>NCT02742649</DOCNO>
	<brief_summary>The purpose study determine combination two drug ( bimatoprost timolol ) deliver surface eye 10 week well lower intraocular pressure ( IOP ) either drug deliver alone .</brief_summary>
	<brief_title>A Study Evaluate Efficacy Safety Fixed Combination Ocular Insert Subjects With Open-angle Glaucoma Ocular Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Glaucoma , Open-Angle</mesh_term>
	<mesh_term>Ocular Hypertension</mesh_term>
	<mesh_term>Bimatoprost</mesh_term>
	<mesh_term>Timolol</mesh_term>
	<criteria>Key Written inform consent At least 18 year age Diagnosis eye either primary openangle glaucoma ( POAG ) ocular hypertension Best correcteddistance visual acuity score equivalent 20/80 well Stable visual field Central corneal thickness 490 620 micrometer Inclusion Criteria Randomization Visit : IOP eye ≥ 23 mmHg T=0hr , ≥ 20 mmHg T=4hr T=8hr . Intereye IOP difference ≤ 5.0 mmHg T=0hr , T=4hr T=8hr . IOP eye ≤ 30 mmHg T=0hr , T=4hr T=8hr . Key Any known contraindication prostaglandin analog ( latanoprost , travoprost , bimatoprost , tafluprost ) timolol A cardiac pulmonary condition opinion Investigator would contraindicate use topical betablocker Use agent know substantial effect IOP plan study period ( e.g . betablockers ) Cuptodisc ratio great 0.8 Significant risk angle closure due pupil dilation , define Shaffer classification less Grade 2 base gonioscopy Ocular , orbital , and/or eyelid surgery type within past six ( 6 ) month screen date Laser surgery glaucoma / ocular hypertension one ( 1 ) eye within last six ( 6 ) month Past history incisional surgery glaucoma time Past history corneal refractive surgery Corneal abnormality would interfere accurate IOP reading applanation tonometer Current participation investigational drug device study participation study within 7 day Screening Inability adequately evaluate retina Subjects require contact lens use study period . Subjects currently punctal occlusion Pregnant , lactate childbearing potential use medically acceptable form birth control</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>